Abstract
Every year 13.3 million people suffer acute kidney injury (AKI), which is associated with a high risk of death or development of long-term chronic kidney disease (CKD) in a substantial percentage of patients besides other organ dysfunctions. To date, the mortality rate per year for AKI exceeds 50 % at least in patients requiring early renal replacement therapy and is higher than the mortality for breast and prostate cancer, heart failure and diabetes combined.
Until now, no effective treatments able to accelerate renal recovery and improve survival post AKI have been developed. In search of innovative and effective strategies to foster the limited regeneration capacity of the kidney, several studies have evaluated the ability of mesenchymal stem cells (MSCs) of different origin as an attractive therapeutic tool. The results obtained in several models of AKI and CKD document that MSCs have therapeutic potential in repair of renal injury, preserving renal function and structure thus prolonging animal survival through differentiation-independent pathways. In this chapter, we have summarized the mechanisms underlying the regenerative processes triggered by MSC treatment, essentially due to their paracrine activity. The capacity of MSC to migrate to the site of injury and to secrete a pool of growth factors and cytokines with anti-inflammatory, mitogenic, and immunomodulatory effects is described. New modalities of cell-to-cell communication via the release of microvesicles and exosomes by MSCs to injured renal cells will also be discussed. The translation of basic experimental data on MSC biology into effective care is still limited to preliminary phase I clinical trials and further studies are needed to definitively assess the efficacy of MSC-based therapy in humans.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Taylor PL, Barker RA, Blume KG et al (2010) Patients beware: commercialized stem cell treatments on the web. Cell Stem Cell 7:43–49
Daley GQ (2012) The promise and perils of stem cell therapeutics. Cell Stem Cell 10:740–749
Ranganath SH, Levy O, Inamdar MS et al (2012) Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell 10:244–258
Rosenzweig A (2006) Cardiac cell therapy-mixed results from mixed cells. N Engl J Med 355:1274–1277
Nowbar AN, Mielewczik M, Karavassilis M et al (2014) Discrepancies in autologous bone marrow stem cell trials and enhancement of ejection fraction (DAMASCENE): weighted regression and meta-analysis. BMJ 348:g2688
Weissman I (2012) Stem cell therapies could change medicine… if they get the chance. Cell Stem Cell 10:663–665
Poulsom R, Forbes SJ, Hodivala-Dilke K et al (2001) Bone marrow contributes to renal parenchymal turnover and regeneration. J Pathol 195:229–235
Ito T, Suzuki A, Imai E et al (2001) Bone marrow is a reservoir of repopulating mesangial cells during glomerular remodeling. J Am Soc Nephrol 12:2625–2635
Li B, Morioka T, Uchiyama M et al (2006) Bone marrow cell infusion ameliorates progressive glomerulosclerosis in an experimental rat model. Kidney Int 69:323–330
Friedenstein AJ, Chailakhjan RK, Lalykina KS (1970) The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 3:393–403
Dominici M, Le Blanc K, Mueller I et al (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315–317
Bianco P, Robey PG, Simmons PJ (2008) Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2:313–319
Bianco P, Cao X, Frenette PS et al (2013) The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nat Med 19:35–42
Uccelli A, Moretta L, Pistoia V (2008) Mesenchymal stem cells in health and disease. Nat Rev Immunol 8:726–736
Edwards RG, Hollands P (2007) Will stem cells in cord blood, amniotic fluid, bone marrow and peripheral blood soon be unnecessary in transplantation? Reprod Biomed Online 14:396–401
Panepucci RA, Siufi JL, Silva WA Jr et al (2004) Comparison of gene expression of umbilical cord vein and bone marrow-derived mesenchymal stem cells. Stem Cells 22:1263–1278
Crisan M, Yap S, Casteilla L et al (2008) A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3:301–313
Caplan AI, Correa D (2011) The MSC: an injury drugstore. Cell Stem Cell 9:11–15
Teixeira FG, Carvalho MM, Sousa N et al (2013) Mesenchymal stem cells secretome: a new paradigm for central nervous system regeneration? Cell Mol Life Sci 70:3871–3882
Wagner J, Kean T, Young R et al (2009) Optimizing mesenchymal stem cell-based therapeutics. Curr Opin Biotechnol 20:531–536
Kupcova Skalnikova H (2013) Proteomic techniques for characterisation of mesenchymal stem cell secretome. Biochimie 95:2196–2211
Drago D, Cossetti C, Iraci N et al (2013) The stem cell secretome and its role in brain repair. Biochimie 95:2271–2285
Bronckaers A, Hilkens P, Martens W et al (2014) Mesenchymal stem/stromal cells as a pharmacological and therapeutic approach to accelerate angiogenesis. Pharmacol Ther 143:181–196
Abumaree M, Al Jumah M, Pace RA et al (2012) Immunosuppressive properties of mesenchymal stem cells. Stem Cell Rev 8:375–392
Bartholomew A, Sturgeon C, Siatskas M et al (2002) Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30:42–48
Di Nicola M, Carlo-Stella C, Magni M et al (2002) Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99:3838–3843
Casiraghi F, Remuzzi G, Perico N (2014) Mesenchymal stromal cells to promote kidney transplantation tolerance. Curr Opin Organ Transplant 19:47–53
English K (2013) Mechanisms of mesenchymal stromal cell immunomodulation. Immunol Cell Biol 91:19–26
Kim J, Hematti P (2009) Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages. Exp Hematol 37:1445–1453
Baglio SR, Pegtel DM, Baldini N (2012) Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell-free therapy. Front Physiol 3:359
Tomasoni S, Longaretti L, Rota C et al (2013) Transfer of growth factor receptor mRNA via exosomes unravels the regenerative effect of mesenchymal stem cells. Stem Cells Dev 22:772–780
Ratajczak J, Wysoczynski M, Hayek F et al (2006) Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 20:1487–1495
Camussi G, Deregibus MC, Bruno S et al (2010) Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int 78:838–848
Devarajan P (2006) Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol 17:1503–1520
Coca SG, Yusuf B, Shlipak MG et al (2009) Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 53:961–973
Star RA (1998) Treatment of acute renal failure. Kidney Int 54:1817–1831
Grino JM (1994) BN 52021: a platelet activating factor antagonist for preventing post- transplant renal failure. A double-blind, randomized study. The BN 52021 Study Group in Renal Transplantation. Ann Intern Med 121:345–347
Haug CE, Colvin RB, Delmonico FL et al (1993) A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients. Transplantation 55:766–772
Bonventre JV (2003) Dedifferentiation and proliferation of surviving epithelial cells in acute renal failure. J Am Soc Nephrol 14(Suppl 1):S55–S61
Lameire N, Van Biesen W, Vanholder R (2008) Acute kidney injury. Lancet 372:1863–1865
Benigni A, Morigi M, Remuzzi G (2010) Kidney regeneration. Lancet 375:1310–1317
Aejaz HM, Aleem AK, Parveen N et al (2007) Stem cell therapy-present status. Transplant Proc 39:694–699
Daley GQ, Scadden DT (2008) Prospects for stem cell-based therapy. Cell 132:544–548
Lindvall O, Kokaia Z (2006) Stem cells for the treatment of neurological disorders. Nature 441:1094–1096
Laflamme MA, Murry CE (2005) Regenerating the heart. Nat Biotechnol 23:845–856
Little MH (2006) Regrow or repair: potential regenerative therapies for the kidney. J Am Soc Nephrol 17:2390–2401
Cantley LG (2005) Adult stem cells in the repair of the injured renal tubule. Nat Clin Pract Nephrol 1:22–32
Morigi M, Benigni A, Remuzzi G et al (2006) The regenerative potential of stem cells in acute renal failure. Cell Transplant 15(Suppl 1):S111–S117
Morigi M, Imberti B, Zoja C et al (2004) Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J Am Soc Nephrol 15:1794–1804
Herrera MB, Bussolati B, Bruno S et al (2004) Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. Int J Mol Med 14:1035–1041
Togel F, Hu Z, Weiss K et al (2005) Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol 289:F31–F42
Morigi M, Introna M, Imberti B et al (2008) Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice. Stem Cells 26:2075–2082
Morigi M, Rota C, Montemurro T et al (2010) Life-sparing effect of human cord blood-mesenchymal stem cells in experimental acute kidney injury. Stem Cells 28:513–522
Rota C, Imberti B, Pozzobon M et al (2012) Human amniotic fluid stem cell preconditioning improves their regenerative potential. Stem Cells Dev 21:1911–1923
Kim JH, Park DJ, Yun JC et al (2012) Human adipose tissue-derived mesenchymal stem cells protect kidneys from cisplatin nephrotoxicity in rats. Am J Physiol Renal Physiol 302:F1141–F1150
Katsuno T, Ozaki T, Saka Y et al (2013) Low serum cultured adipose tissue-derived stromal cells ameliorate acute kidney injury in rats. Cell Transplant 22:287–297
Flynn A, Barry F, O'Brien T (2007) UC blood-derived mesenchymal stromal cells: an overview. Cytotherapy 9:717–726
Sanchez-Ramos J (2006) Stem cells from umbilical cord blood. Semin Reprod Med 24:358–369
Erices A, Conget P, Minguell JJ (2000) Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 109:235–242
Lee OK, Kuo TK, Chen WM et al (2004) Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 103:1669–1675
Seres KB, Hollands P (2010) Cord blood: the future of regenerative medicine? Reprod Biomed Online 20:98–102
Du T, Cheng J, Zhong L et al (2012) The alleviation of acute and chronic kidney injury by human Wharton’s jelly-derived mesenchymal stromal cells triggered by ischemia-reperfusion injury via an endocrine mechanism. Cytotherapy 14:1215–1227
Fang TC, Pang CY, Chiu SC et al (2012) Renoprotective effect of human umbilical cord-derived mesenchymal stem cells in immunodeficient mice suffering from acute kidney injury. PLoS One 7, e46504
De Coppi P, Bartsch G Jr, Siddiqui MM et al (2007) Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 25:100–106
Gupta S, Verfaillie C, Chmielewski D et al (2002) A role for extrarenal cells in the regeneration following acute renal failure. Kidney Int 62:1285–1290
Bi B, Schmitt R, Israilova M et al (2007) Stromal cells protect against acute tubular injury via an endocrine effect. J Am Soc Nephrol 18:2486–2496
Togel F, Weiss K, Yang Y et al (2007) Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am J Physiol Renal Physiol 292:F1626–F1635
Hirschberg R, Ding H (1998) Mechanisms of insulin-like growth factor-I-induced accelerated recovery in experimental ischemic acute renal failure. Miner Electrolyte Metab 24:211–219
Imberti B, Morigi M, Tomasoni S et al (2007) Insulin-like growth factor-1 sustains stem cell mediated renal repair. J Am Soc Nephrol 18:2921–2928
Togel F, Zhang P, Hu Z et al (2009) VEGF is a mediator of the renoprotective effects of multipotent marrow stromal cells in acute kidney injury. J Cell Mol Med 13:2109–2114
Hagiwara M, Shen B, Chao L et al (2008) Kallikrein-modified mesenchymal stem cell implantation provides enhanced protection against acute ischemic kidney injury by inhibiting apoptosis and inflammation. Hum Gene Ther 19:807–819
Mias C, Trouche E, Seguelas MH et al (2008) Ex vivo pretreatment with melatonin improves survival, proangiogenic/mitogenic activity, and efficiency of mesenchymal stem cells injected into ischemic kidney. Stem Cells 26:1749–1757
Xinaris C, Morigi M, Benedetti V et al (2013) A novel strategy to enhance mesenchymal stem cell migration capacity and promote tissue repair in an injury specific fashion. Cell Transplant 22:423–436
Bruno S, Grange C, Deregibus MC et al (2009) Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol 20:1053–1067
Collino F, Deregibus MC, Bruno S et al (2010) Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs. PLoS One 5, e11803
Lindoso RS, Collino F, Bruno S et al (2014) Extracellular vesicles released from mesenchymal stromal cells modulate miRNA in renal tubular cells and inhibit ATP depletion injury. Stem Cells Dev 23(15):1809–1819
Kunter U, Rong S, Moeller MJ et al (2011) Mesenchymal stem cells as a therapeutic approach to glomerular diseases: benefits and risks. Kidney Int Suppl 1:68–73
Ninichuk V, Gross O, Segerer S et al (2006) Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice. Kidney Int 70:121–129
Guillot PV, Cook HT, Pusey CD et al (2008) Transplantation of human fetal mesenchymal stem cells improves glomerulopathy in a collagen type I alpha 2-deficient mouse. J Pathol 214:627–636
Choi S, Park M, Kim J et al (2009) The role of mesenchymal stem cells in the functional improvement of chronic renal failure. Stem Cells Dev 18:521–529
Cavaglieri RC, Martini D, Sogayar MC et al (2009) Mesenchymal stem cells delivered at the subcapsule of the kidney ameliorate renal disease in the rat remnant kidney model. Transplant Proc 41:947–951
Semedo P, Correa-Costa M, Antonio Cenedeze M et al (2009) Mesenchymal stem cells attenuate renal fibrosis through immune modulation and remodeling properties in a rat remnant kidney model. Stem Cells 27:3063–3073
Kunter U, Rong S, Djuric Z et al (2006) Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis. J Am Soc Nephrol 17:2202–2212
Kunter U, Rong S, Boor P et al (2007) Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes. J Am Soc Nephrol 18:1754–1764
Sun L, Akiyama K, Zhang H et al (2009) Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans. Stem Cells 27:1421–1432
Zoja C, Garcia PB, Rota C et al (2012) Mesenchymal stem cell therapy promotes renal repair by limiting glomerular podocyte and progenitor cell dysfunction in adriamycin-induced nephropathy. Am J Physiol Renal Physiol 303:F1370–F1381
Gooch A, Doty J, Flores J et al (2008) Initial report on a phase I clinical trial: prevention and treatment of post-operative acute kidney injury with allogeneic mesenchymal stem cell in patients who require on-pump cardiac surgery. Cell Ther Transplant [Online] 1:31–35
Togel FE, Westenfelder C (2010) Mesenchymal stem cells: a new therapeutic tool for AKI. Nat Rev Nephrol 6:179–183
Acknowledgments
The authors thank Manuela Passera and Antonella Piccinelli for their help in preparing this manuscript.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Morigi, M., Rota, C., Remuzzi, G. (2016). Mesenchymal Stem Cells in Kidney Repair. In: Gnecchi, M. (eds) Mesenchymal Stem Cells. Methods in Molecular Biology, vol 1416. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3584-0_5
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3584-0_5
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3582-6
Online ISBN: 978-1-4939-3584-0
eBook Packages: Springer Protocols